Patients with high-grade astrocytomas and high EMMPRIN mRNA levels (n = 36) did not have worse overall survival than patients with low EMMPRIN mRNA expression (n = 41) (p = 0.7274, by log-rank test; 95 % CI: 0.4327–1.711) (Fig. 4b). The gene discussed is BSG; the disease is astrocytoma (excluding glioblastoma).